PSB 36
PSB 36 structure
|
Common Name | PSB 36 | ||
|---|---|---|---|---|
| CAS Number | 524944-72-7 | Molecular Weight | 386.48800 | |
| Density | 1.304g/cm3 | Boiling Point | 646.008ºC at 760 mmHg | |
| Molecular Formula | C21H30N4O3 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 344.493ºC | |
|
The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice.
Diabetes 62(6) , 2026-35, (2013) Islet allograft survival limits the long-term success of islet transplantation as a potential curative therapy for type 1 diabetes. A number of factors compromise islet survival, including recurrent diabetes. We investigated whether CD39, an ectonucleotidase ... |
|
|
Diadenosine diphosphate (Ap₂A) delays neutrophil apoptosis via the adenosine A2A receptor and cAMP/PKA pathway.
Biochem. Cell Biol. 92(5) , 420-4, (2014) Diadenosine polyphosphates have been shown to inhibit neutrophil apoptosis, but mechanisms of the antiapoptotic effect are not known. Diadenosine diphosphate (Ap2A) is the simplest naturally occurring diadenosine polyphosphate, and its effect on neutrophil ap... |
|
|
Antinociceptive effects of novel A2B adenosine receptor antagonists.
J. Pharmacol. Exp. Ther. 308 , 358-366, (2004) Caffeine, an adenosine A1, A2A, and A2B receptor antagonist, is frequently used as an adjuvant analgesic in combination with nonsteroidal anti-inflammatory drugs or opioids. In this study, we have examined the effects of novel specific adenosine receptor anta... |